SCHEMBL9007073

SCHEMBL9007073

COC(=O)c1ccc(CC(C)NC[C@@H](O)c2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 13/20 0.56
ADRB1 P08588 12/20 0.56
CYP3A4 P08684 3/20 0.53
CYP2D6 P10635 3/20 0.53
USP2 O75604 2/20 0.53
ADRA1A P35348 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C9 P11712 2/20 0.53
NR1I2 O75469 1/20 0.53
HTR1A P08908 1/20 0.53
ADRA2A P08913 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
ADRA2B P18089 1/20 0.53
ADRA2C P18825 1/20 0.53
CHRM3 P20309 1/20 0.53
SLC6A2 P23975 1/20 0.53
HTR2A P28223 1/20 0.53
HTR2C P28335 1/20 0.53
SLC6A4 P31645 1/20 0.53
HRH1 P35367 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9007077 1.00 ADRB3 (0.56) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL11053844 1.00 ADRB3 (0.56) ADRB3ADRB1CYP3A4CYP2D6USP2
Hydrochloric Acid SCHEMBL11040417 0.99 ADRB3 (0.55) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL10773274 0.93 ADRB1 (0.60) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL10772579 0.90 ADRB1 (0.69) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL9007030 0.90 ADRB1 (0.69) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL9006832 0.90 ADRB1 (0.69) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL11039896 0.90 ADRB2 (0.47) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL11039262 0.89 ADRB1 (0.49) ADRB3ADRB1CYP3A4CYP2D6USP2
SCHEMBL9631756 0.88 ADRB3 (0.51) ADRB3ADRB1CYP3A4CYP2D6USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0403360-B1 Use of phenylethanolamines for the preparation of a medicament for treating ophthalmologic disorders SANOFI SA (FR) 1996-10-16 EP claimed
EP-0255415-B1 USE OF PHENYLETHANOLAMINES FOR THE PREPARATION OF MEDICAMENTS ACTING ON GASTROINTESTINAL TROUBLES ELF SANOFI (FR) 1993-04-14 EP claimed
US-5002946-A Gastrointestinal diseases associated with smooth muscle contractions SANOFI (FR) 1991-03-26 US claimed
EP-0255415-A2 Use of phenylethanolamines for the preparation of medicaments acting on gastrointestinal troubles ELF SANOFI (FR) 1988-02-03 EP claimed
EP-0403360-B1 Use of phenylethanolamines for the preparation of a medicament for treating ophthalmologic disorders SANOFI SA (FR) 1996-10-16 EP disclosed
US-5236951-A Administering a phenylethanolamine derivative SANOFI (FR) 1993-08-17 US disclosed
EP-0255415-B1 USE OF PHENYLETHANOLAMINES FOR THE PREPARATION OF MEDICAMENTS ACTING ON GASTROINTESTINAL TROUBLES ELF SANOFI (FR) 1993-04-14 EP disclosed
US-5002946-A Gastrointestinal diseases associated with smooth muscle contractions SANOFI (FR) 1991-03-26 US disclosed
EP-0403360-A2 Use of phenylethanolamines for the preparation of a medicament for treating ophthalmologic disorders SANOFI (FR) 1990-12-19 EP disclosed
EP-0255415-A2 Use of phenylethanolamines for the preparation of medicaments acting on gastrointestinal troubles ELF SANOFI (FR) 1988-02-03 EP disclosed